- Home
- RCEL vs NEN Comparison
RCEL vs NEN Comparison
Compare RCEL & NEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCEL
- NEN
- Stock Information
- Founded
- RCEL N/A
- NEN 1977
- Country
- RCEL United States
- NEN United States
- Employees
- RCEL N/A
- NEN N/A
- Industry
- RCEL Medical/Dental Instruments
- NEN Building operators
- Sector
- RCEL Health Care
- NEN Real Estate
- Exchange
- RCEL Nasdaq
- NEN Nasdaq
- Market Cap
- RCEL 240.6M
- NEN 277.7M
- IPO Year
- RCEL N/A
- NEN N/A
- Fundamental
- Price
- RCEL $6.97
- NEN $77.25
- Analyst Decision
- RCEL Strong Buy
- NEN
- Analyst Count
- RCEL 4
- NEN 0
- Target Price
- RCEL $17.25
- NEN N/A
- AVG Volume (30 Days)
- RCEL 197.1K
- NEN 592.0
- Earning Date
- RCEL 05-08-2025
- NEN 01-01-0001
- Dividend Yield
- RCEL N/A
- NEN 6.21%
- EPS Growth
- RCEL N/A
- NEN 87.60
- EPS
- RCEL N/A
- NEN 4.46
- Revenue
- RCEL $71,661,000.00
- NEN $81,814,652.00
- Revenue This Year
- RCEL $62.33
- NEN N/A
- Revenue Next Year
- RCEL $30.59
- NEN N/A
- P/E Ratio
- RCEL N/A
- NEN $17.32
- Revenue Growth
- RCEL 41.35
- NEN 8.57
- 52 Week Low
- RCEL $6.90
- NEN $67.50
- 52 Week High
- RCEL $14.16
- NEN $84.00
- Technical
- Relative Strength Index (RSI)
- RCEL 28.06
- NEN 43.89
- Support Level
- RCEL $9.50
- NEN $76.00
- Resistance Level
- RCEL $9.85
- NEN $78.75
- Average True Range (ATR)
- RCEL 0.53
- NEN 0.45
- MACD
- RCEL -0.20
- NEN 0.02
- Stochastic Oscillator
- RCEL 10.03
- NEN 31.17
About RCEL Avita Medical Inc.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the US with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.
About NEN New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership
New England Realty Associates LP is engaged in the business of acquiring, developing, holding for investment, operating and selling real estate. The Partnership owns and operates various residential apartments, condominium units and commercial properties located in Massachusetts and New Hampshire. The company generates revenue from rental income from residential and commercial properties recognized over the term of the related lease. The long-term goals of the Partnership are to manage, rent and improve its properties and to acquire additional properties with income and capital appreciation potential as suitable opportunities arise.